Advertisement
Advertisement

AVIR

AVIR logo

Atea Pharmaceuticals, Inc. Common Stock

4.88
USD
Sponsored
+0.01
+0.21%
Jul 07, 15:59 UTC -4
Closed
exchange

After-Market

4.88

0.00
0.00%

AVIR Earnings Reports

Positive Surprise Ratio

AVIR beat 16 of 23 last estimates.

70%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.57
Implied change from Q1 26 (Revenue/ EPS)
--
/
+1.79%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+29.55%

Atea Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On May 12, 2026, AVIR reported earnings of -0.56 USD per share (EPS) for Q1 26, beating the estimate of -0.60 USD, resulting in a 5.28% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -16.91% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.57 USD, with revenue projected to reach -- USD, implying an increase of 1.79% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Atea Pharmaceuticals, Inc. Common Stock reported EPS of -$0.56, beating estimates by 5.28%, and revenue of $0.00, 0% as expectations.
The stock price moved down -16.91%, changed from $5.50 before the earnings release to $4.57 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 3 analysts, Atea Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.57 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement